| Description: | The Scales for the Assessment of Positive Symptoms (SAPS) is a 34-item assessment tool to measure positive symptoms in schizophrenia. The scale was developed in the early 1980s. |
|---|---|
| Disease States: | Schizophrenia |
| Validated Uses: | Screening, Treatment Monitoring & Evaluation, Symptom Severity |
| Administration Method: | Clinician-report |
| Time to administer: | 20 minutes |
| Commonly used in: | Clinical Trials & Research, Clinical Practice |
| Detailed Description: | The Scales for the Assessment of Positive Symptoms (SAPS) is a 34-item assessment tool to measure positive symptoms in schizophrenia. The scale was developed in the early 1980s.1 |
| Scale Validity: | The reliability and validity of the SAPS have been assessed in multiple studies. Earlier studies found interrater reliability to be consistent.1,3 |
| Alternative Versions: | The SAPS is complemented by the Scale for the Assessment of Negative Symptoms (SANS), which is a similar tool that evaluates negative symptoms in schizophrenia. Together the scales are a comprehensive combination that can measure schizophrenia symptoms and assess changes over time.1 |
| Cited Limitations: | One criticism is that the duality of the positive and negative scales is not diverse or complex enough for schizophrenia symptoms.1 |
Footnotes:
Supporting references are as follows:
Disease State: Schizophrenia1-3; Validated Uses: Screening, Treatment Monitoring & Evaluation,1,3-5 Symptom Severity3-5; Administration Method: Clinician-report1,3,5; Time to Administer: 20 minutes5; Commonly used in: Clinical trials and research, Clinical Practice1
This resource is intended for educational purposes only and is intended for US healthcare professionals. Healthcare professionals should use independent medical judgment. All decisions regarding patient care must be handled by a healthcare professional and be made based on the unique needs of each patient.
ABBV-US-01587-MC, Version 1.0
Approved 04/2024
AbbVie Medical Affairs